SEARCH

SEARCH BY CITATION

References

  • 1
    Ennis SR, Rios-Vargas M, Albert NG. The Hispanic Population: 2010: 2010 Census Briefs. Washington, DC: United States Census Bureau; 2011.
  • 2
    US Census Bureau. Current Population Survey: Annual Social and Economic (ASEC) Supplement Survey, 2010. Internet release date June 2011. Available at: http://www.census.gov/population/www/socdemo/hispanic/cps2010.html. Accessed July 18, 2012.
  • 3
    DeNavas-Walt C, Proctor BD, Smith JC. Income, Poverty, and Health Insurance Coverage in the United States: 2010. Washington, DC: US Department of Commerce, United States Census Bureau; 2011.
  • 4
    Chao A, Gilliland FD, Hunt WC, Bulterys M, Becker TM, Key CR. Increasing incidence of colon and rectal cancer among Hispanics and American Indians in New Mexico (United States), 1969-94. Cancer Causes Control. 1998; 9: 137-144.
  • 5
    Pinheiro PS, Sherman RL, Trapido EJ, et al. Cancer incidence in first generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2162-2169.
  • 6
    Wilkinson JD, Wohler-Torres B, Trapido E, et al. Cancer trends among Hispanic men in South Florida, 1981-1998. Cancer. 2002; 94: 1183-1190.
  • 7
    Lara M, Gamboa C, Kahramanian MI, Morales LS, Bautista DE. Acculturation and Latino health in the United States: a review of the literature and its sociopolitical context. Annu Rev Public Health. 2005; 26: 367-397.
  • 8
    Singh GK, Hiatt RA. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979-2003. Int J Epidemiol. 2006; 35: 903-919.
  • 9
    Ho GY, Figueroa-Valles NR, De La Torre-Feliciano T, et al. Cancer disparities between mainland and island Puerto Ricans. Rev Panam Salud Publica. 2009; 25: 394-400.
  • 10
    Cokkinides V, Bandi P, Siegel R, Jemal A. Cancer-related risk factors and preventive measures in US Hispanics/Latinos. CA Cancer J Clin. In press.
  • 11
    Howe HL, Lake A, Schymura MJ, Edwards BK. Indirect method to estimate specific Hispanic group cancer rates. Cancer Causes Control. 2009; 20: 1215-1226.
  • 12
    Martinez-Tyson D, Pathak EB, Soler-Vila H, Flores AM. Looking under the Hispanic umbrella: cancer mortality among Cubans, Mexicans, Puerto Ricans and other Hispanics in Florida. J Immigr Minor Health. 2009; 11: 249-257.
  • 13
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 18 Regs Public Use, Nov. 2011 Sub (2000-2009)-Linked to County Attributes-Total US, 1969-2009 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2012.
  • 14
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 13 Regs Public Use, Nov. 2010 Sub (1992-2009)-Linked to County Attributes-Total US, 1969-2009 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2012.
  • 15
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence-CiNA Analytic File, 1995-2009, for Expanded Races, custom file with county, ACS Facts & Figures Projection Project, NAACCR. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2012.
  • 16
    Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19: 335-351.
  • 17
    Joinpoint Regression Program, Version 3.5.2. Bethesda, MD: Statistical Methodology and Applications Branch, National Cancer Institute; 2011.
  • 18
    Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology.3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 19
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Mortality-All COD, Public Use With State, Total US (1969-2009). Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2012; underlying mortality data provided by the National Center for Health Statistics.
  • 20
    World Health Organization. Manual of the International Statistical Classification of Diseases Injuries and Causes of Death. Vol 1. 9th rev. Geneva, Switzerland: World Health Organization; 1975.
  • 21
    World Health Organization. Manual of the International Statistical Classification of Diseases Injuries and Causes of Death. Vol 1. 10th rev. Geneva, Switzerland: World Health Organization; 1990.
  • 22
    Surveillance Research Program. National Cancer Institute SEER*Stat software, version 7.0.9. Bethesda, MD: National Cancer Institute; 2012.
  • 23
    Chen HS, Portier K, Ghosh K, et al. Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortality. Cancer. 2012; 118: 1091-1099.
  • 24
    Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, eds. SEER Cancer Statistics Review, 1975-2009. Bethesda, MD: National Cancer Institute; 2012.
  • 25
    Rosenberg HM, Maurer JD, Sorlie PD, et al. Quality of death rates by race and Hispanic origin: a summary of current research, 1999. Vital Health Stat 2. 1999( 128): 1-13.
  • 26
    Arias E, Schauman WS, Eschbach K, Sorlie PD, Backlund E. The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 2. 2008;( 148): 1-23.
  • 27
    Arias E. United States life tables by Hispanic origin. Vital Health Stat 2. 2010( 152): 1-33.
  • 28
    Statistical Research and Applications Branch, National Cancer Institute. DevCan Probability of Developing or Dying of Cancer Software. Version 6.6.1. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; 2012.
  • 29
    Reyes-Ortiz CA, Eschbach K, Zhang DD, Goodwin JS. Neighborhood composition and cancer among Hispanics: tumor stage and size at time of diagnosis. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2931-2936.
  • 30
    Escarce J, Kapur K. Access to and quality of health care. In: Tienda M, Mitchell F, eds. Hispanics and the Future of America. Washington, DC: Committee on Transforming Our Common Destiny, National Research Council National Academy Press; 2006: 410-415.
  • 31
    Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1950-1962.
  • 32
    Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008; 9: 222-231.
  • 33
    Lantz PM, Mujahid M, Schwartz K, et al. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health. 2006; 96: 2173-2178.
  • 34
    Watlington AT, Byers T, Mouchawar J, Sauaia A, Ellis J. Does having insurance affect differences in clinical presentation between Hispanic and non-Hispanic white women with breast cancer? Cancer. 2007; 109: 2093-2099.
  • 35
    Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic paradox. Ethn Dis. 2001; 11: 496-518.
  • 36
    Turra CM, Elo IT. The impact of salmon bias on the Hispanic mortality advantage: new evidence from Social Security data. Popul Res Policy Rev. 2008; 27: 515-530.
  • 37
    Pollitt RA, Clarke CA, Swetter SM, Peng DH, Zadnick J, Cockburn M. The expanding melanoma burden in California hispanics: importance of socioeconomic distribution, histologic subtype, and anatomic location. Cancer. 2011; 117: 152-161.
  • 38
    Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005; 97: 439-448.
  • 39
    Sweeney C, Baumgartner KB, Byers T, et al. Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control. 2008; 19: 391-401.
  • 40
    John EM, Phipps AI, Davis A, Koo J. Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2905-2913.
  • 41
    Breen N, Cronin KA, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer. 2007; 109: 2405-2409.
  • 42
    Press R, Carrasquillo O, Sciacca RR, Giardina EG. Racial/ethnic disparities in time to follow-up after an abnormal mammogram. J Womens Health (Larchmt). 2008; 17: 923-930.
  • 43
    Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN. Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 2011; 37: 568-575.
  • 44
    Parise CA, Bauer KR, Caggiano V. Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California. Cancer. 2012; 118: 2516-2524.
  • 45
    Bickell NA, Shastri K, Fei K, et al. A tracking and feedback registry to reduce racial disparities in breast cancer care. J Natl Cancer Inst. 2008; 100: 1717-1723.
  • 46
    Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res. 2007; 9: R28.
  • 47
    Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007; 356: 1670-1674.
  • 48
    DeSantis C, Howlader N, Cronin KA, Jemal A. Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev. 2011; 20: 733-739.
  • 49
    Berry DA, Cronin KA, Plevritis SK, et al; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 1784-1792.
  • 50
    DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011; 61: 409-418.
  • 51
    Soto-Salgado M, Suarez E, Calo W, Cruz-Correa M, Figueroa-Valles NR, Ortiz AP. Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites, and non-Hispanic blacks in the United States, 1998-2002. Cancer. 2009; 115: 3016-3023.
  • 52
    De Jesus-Monge WE, Gonzalez-Keelan C, Zhao R, Hamilton SR, Rodriguez-Bigas M, Cruz-Correa M. Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer. 2010; 9: 155-166.
  • 53
    Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009; 59: 366-378.
  • 54
    Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006; 42: 216-227.
  • 55
    Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001; 91: 854-862.
  • 56
    Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009; 125: 171-180.
  • 57
    Ferrari P, Jenab M, Norat T, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2007; 121: 2065-2072.
  • 58
    Samad AK, Taylor RS, Marshall T, Chapman MA. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis. 2005; 7: 204-213.
  • 59
    Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010; 376: 1741-1750.
  • 60
    Cho E, Smith-Warner SA, Spiegelman D, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst. 2004; 96: 1015-1022.
  • 61
    Levin B, Lieberman DA, McFarland B, et al; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008; 58: 130-160.
  • 62
    Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303: 235-241.
  • 63
    He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA. The association of diabetes with colorectal cancer risk: the Multiethnic Cohort. Br J Cancer. 2010; 103: 120-126.
  • 64
    Centers for Disease Control and Prevention. National Health Interview Survey Public Use Data File 2010. Atlanta, GA: National Center for Health Statistics, Centers for Disease Control and Prevention; 2011.
  • 65
    Lee W, Nelson R, Mailey B, Duldulao MP, Garcia-Aguilar J, Kim J. Socioeconomic factors impact colon cancer outcomes in diverse patient populations. J Gastrointest Surg. 2012; 16: 692-704.
  • 66
    Wong R. Proximal tumors are associated with greater mortality in colon cancer. J Gen Intern Med. 2010; 25: 1157-1163.
  • 67
    Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008; 57: 1226-1228.
  • 68
    Fagan P, Moolchan ET, Lawrence D, Fernander A, Ponder PK. Identifying health disparities across the tobacco continuum. Addiction. 2007; 102(suppl 2): 5-29.
  • 69
    Bethel JW, Schenker MB. Acculturation and smoking patterns among Hispanics: a review. Am J Prev Med. 2005; 29: 143-148.
  • 70
    Haiman CA, Stram DO, Wilkens LR, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006; 354: 333-342.
  • 71
    Chang JS, Wrensch MR, Hansen HM, et al. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer. 2008; 123: 2095-2104.
  • 72
    Chang JS, Wrensch MR, Hansen HM, et al. Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis. 2009; 30: 78-87.
  • 73
    Saeed AM, Toonkel R, Glassberg MK, et al. The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database [published online ahead of print April 23, 2012]. Cancer. doi: 10.1002/cncr.26686.
  • 74
    Hayn MH, Orom H, Shavers VL, et al. Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer [published online ahead of print March 31, 2012]. Cancer. doi: 10.1002/cncr.26103.
  • 75
    Shavers VL, Brown ML, Potosky AL, et al. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med. 2004; 19: 146-155.
  • 76
    Lam JS, Desai M, Mansukhani MM, Benson MC, Goluboff ET. Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy? J Urol. 2003; 170( 6 pt 1): 2288-2291.
  • 77
    Lam JS, Sclar JD, Desai M, Mansukhani MM, Benson MC, Goluboff ET. Is Hispanic race an important predictor of treatment failure following radical prostatectomy for prostate cancer? J Urol. 2004; 172( 5 pt 1): 1856-1859.
  • 78
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29.
  • 79
    Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Duchane J, Carroll PR. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE. Cancer. 2006; 106: 789-795.
  • 80
    Gallo LC, Penedo FJ, Espinosa de los Monteros K, Arguelles W. Resiliency in the face of disadvantage: do Hispanic cultural characteristics protect health outcomes? J Pers. 2009; 77: 1707-1746.
  • 81
    Morales LS, Lara M, Kington RS, Valdez RO, Escarce JJ. Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved. 2002; 13: 477-503.
  • 82
    de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012; 13: 607-615.
  • 83
    Canto MT, Chu KC. Annual cancer incidence rates for Hispanics in the United States: surveillance, epidemiology, and end results, 1992-1996. Cancer. 2000; 88: 2642-2652.
  • 84
    Thomas DB, Karagas MR. Cancer in first and second generation Americans. Cancer Res. 1987; 47: 5771-5776.
  • 85
    Bertuccio P, Chatenoud L, Levi F, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009; 125: 666-673.
  • 86
    Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst. 2006; 98: 1445-1452.
  • 87
    Wu X, Chen VW, Andrews PA, Ruiz B, Correa P. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control. 2007; 18: 585-593.
  • 88
    Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991; 325: 1132-1136.
  • 89
    Shibata A, Parsonnet J. Stomach cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. New York: Oxford University Press; 2006: 707-720.
  • 90
    Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000; 22: 283-297.
  • 91
    Torres J, Leal-Herrera Y, Perez-Perez G, et al. A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis. 1998; 178: 1089-1094.
  • 92
    Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000; 181: 1359-1363.
  • 93
    Replogle ML, Glaser SL, Hiatt RA, Parsonnet J. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol. 1995; 142: 856-863.
  • 94
    Tsai CJ, Perry S, Sanchez L, Parsonnet J. Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. Am J Epidemiol. 2005; 162: 351-357.
  • 95
    Chang ET, Gomez SL, Fish K, et al. Gastric cancer incidence among Hispanics in California: patterns by time, nativity, and neighborhood characteristics. Cancer Epidemiol Biomarkers Prev. 2012; 21: 709-719.
  • 96
    Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol. 2012; 175: 54-59.
  • 97
    Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008; 19: 689-701.
  • 98
    World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: American Institute for Cancer Research; 2007.
  • 99
    Duell EJ, Travier N, Lujan-Barroso L, et al. Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr. 2011; 94: 1266-1275.
  • 100
    Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009; 45: 2867-2873.
  • 101
    Al-Refaie WB, Tseng JF, Gay G, et al. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base. Cancer. 2008; 113: 461-469.
  • 102
    Kim J, Sun CL, Mailey B, et al. Race and ethnicity correlate with survival in patients with gastric adenocarcinoma. Ann Oncol. 2010; 21: 152-160.
  • 103
    Al-Refaie WB, Gay G, Virnig BA, et al. Variations in gastric cancer care: a trend beyond racial disparities. Cancer. 2010; 116: 465-475.
  • 104
    Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009; 27: 1485-1491.
  • 105
    Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer. 1998; 75: 347-354.
  • 106
    Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004; 127(5 suppl 1): S5-S16.
  • 107
    Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004; 127: 1372-1380.
  • 108
    Flores YN, Yee HF Jr, Leng M, et al. Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol. 2008; 103: 2231-2238.
    Direct Link:
  • 109
    Mast EE, Margolis HS, Fiore AE, et al; Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005; 54( RR-16): 1-31.
  • 110
    Mast EE, Weinbaum CM, Fiore AE, et al; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006; 55( RR-16): 1-33; quiz CE1-CE4.
  • 111
    Centers for Disease Control and Prevention (CDC). Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep. 2011; 60: 1709-1711.
  • 112
    Flores YN, Lang CM, Salmeron J, Bastani R. Risk factors for liver disease and associated knowledge and practices among Mexican adults in the US and Mexico. J Community Health. 2012; 37: 403-411.
  • 113
    Buchschacher GL, Wong-Staal F. Etiology of cancer: viruses, section one, RNA viruses. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2005: 165-173.
  • 114
    International Agency for Research on Cancer (IARC). Alcohol drinking. Vol 44. Lyon, France: IARC; 1988: 255-259.
  • 115
    Randolph WM, Stroup-Benham C, Black SA, Markides KS. Alcohol use among Cuban-Americans, Mexican-Americans, and Puerto Ricans. Alcohol Health Res World. 1998; 22: 265-269.
  • 116
    Naimi TS, Nelson DE, Brewer RD. The intensity of binge alcohol consumption among US adults. Am J Prev Med. 2010; 38: 201-207.
  • 117
    Dong C, Yoon YH, Chen CM, Yi HY. Heavy alcohol use and premature death from hepatocellular carcinoma in the United States, 1999-2006. J Stud Alcohol Drugs. 2011; 72: 892-902.
  • 118
    Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies [published online ahead of print March 23, 2012]. Eur J Cancer.
  • 119
    Coker AL, Eggleston KS, Du XL, Ramondetta L. Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population. Int J Gynecol Cancer. 2009; 19: 13-20.
  • 120
    Patel DA, Barnholtz-Sloan JS, Patel MK, Malone JM Jr, Chuba PJ, Schwartz K. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data. Gynecol Oncol. 2005; 97: 550-558.
  • 121
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010.
  • 122
    Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24: 2137-2150.
  • 123
    Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008; 113(10 suppl): 2855-2864.
  • 124
    Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55: 244-265.
  • 125
    Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1611-1622.
  • 126
    International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. Vol 64. Lyon, France: IARC; 1995: 1-378.
  • 127
    Giuliano AR, Papenfuss M, Schneider A, Nour M, Hatch K. Risk factors for high-risk type human papillomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev. 1999; 8: 615-620.
  • 128
    Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007; 297: 813-819.
  • 129
    Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol. 2007; 110: 87-95.
  • 130
    Gelman A, Nikolajski C, Schwarz EB, Borrero S. Racial disparities in awareness of the human papillomavirus. J Womens Health (Larchmt). 2011; 20: 1165-1173.
  • 131
    Drewry J, Garces-Palacio IC, Scarinci I. Awareness and knowledge about human papillomavirus among Latina immigrants. Ethn Dis. 2010; 20: 327-333.
  • 132
    Kobetz E, Kornfeld J, Vanderpool RC, et al. Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention. J Health Commun. 2010; 15(suppl 3): 22-29.
  • 133
    Nuno T, Castle PE, Harris R, Estrada A, Garcia F; Yuma Project Technical Team. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border. J Womens Health (Larchmt). 2011; 20: 685-693.
  • 134
    Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000; 92: 1500-1510.
  • 135
    Hall HI, Geduld J, Boulos D, et al. Epidemiology of HIV in the United States and Canada: current status and ongoing challenges. J Acquir Immune Defic Syndr. 2009; 51(suppl 1): S13-S20.
  • 136
    Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res. 2002; 89: 191-199.
  • 137
    International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer. 2006; 119: 1108-1124.
  • 138
    International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007; 370: 1609-1621.
  • 139
    International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2007; 120: 885-891.
  • 140
    Tjalma WA, Van Waes TR, Van den Eeden LE, Bogers JJ. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol. 2005; 19: 469-483.
  • 141
    Horner MJ, Altekruse SF, Zou Z, Wideroff L, Katki HA, Stinchcomb DG. U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev. 2011; 20: 591-599.
  • 142
    Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001; 93: 1704-1713.
  • 143
    Shi L, Lebrun LA, Zhu J, Tsai J. Cancer screening among racial/ethnic and insurance groups in the United States: a comparison of disparities in 2000 and 2008. J Health Care Poor Underserved. 2011; 22: 945-961.
  • 144
    Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006; 118: 1591-1602.
  • 145
    Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012; 6: 172-187.
  • 146
    Andia ME, Hsing AW, Andreotti G, Ferreccio C. Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study. Int J Cancer. 2008; 123: 1411-1416.
  • 147
    Shrikhande SV, Barreto SG, Singh S, Udwadia TE, Agarwal AK. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause! Eur J Surg Oncol. 2010; 36: 514-519.
  • 148
    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371: 569-578.
  • 149
    Ren HB, Yu T, Liu C, Li YQ. Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes Control. 2011; 22: 837-847.
  • 150
    Fernandez E, Gallus S, Bosetti C, Franceschi S, Negri E, La Vecchia C. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer. 2003; 105: 408-412.
  • 151
    Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW. Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol. 1999; 149: 1063-1071.